Home > Insider Trading > Filing (0001209191-22-003205)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1868734	Cincor Pharma Inc.	CINC	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1598549	J. Andrew Schwab	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1664281	Kush Parmar	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1753000	5Am Opportunities I, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1753037	5Am Ventures Vi, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1790778	5Am Opportunities I (Gp), Llc	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1829051	5Am Partners Vi, Llc	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-11	3,683,823	$0.00	3,683,823	No	4	C	Indirect	By 5AM Ventures VI, L.P.
Common Stock	Acquisiton	2022-01-11	183,823	$0.00	183,823	No	4	C	Indirect	By 5AM Opportunities I, L.P.
Common Stock	Acquisiton	2022-01-11	157,500	$16.00	3,841,323	No	4	P	Indirect	By 5AM Ventures VI, L.P.
Common Stock	Acquisiton	2022-01-11	312,500	$16.00	496,323	No	4	P	Indirect	By 5AM Opportunities I, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By 5AM Ventures VI, L.P.
No	4	C	Indirect	By 5AM Opportunities I, L.P.
No	4	P	Indirect	By 5AM Ventures VI, L.P.
No	4	P	Indirect	By 5AM Opportunities I, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2022-01-11	9,999,999	$0.00	2,941,176	$0.00
Common Stock	Series B Preferred Stock	Disposition	2022-01-11	2,525,000	$0.00	742,647	$0.00
Common Stock	Series B Preferred Stock	Disposition	2022-01-11	625,000	$0.00	183,823	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.